ID   DSCA1_DROME             Reviewed;        2016 AA.
AC   Q0E9H9; A0A0B4K6Z6; Q0E9H6; Q0E9H8; Q0E9I4; Q0E9J0; Q0E9J7; Q0E9J8; Q0E9J9;
AC   Q0E9K4; Q0E9K7; Q0E9K9; Q0E9L0; Q0E9L5; Q9NBA1;
DT   24-JAN-2024, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 1.
DT   18-JUN-2025, entry version 141.
DE   RecName: Full=Cell adhesion molecule Dscam1 {ECO:0000305};
DE   AltName: Full=Down syndrome cell adhesion molecule homolog {ECO:0000305};
DE   Flags: Precursor;
GN   Name=Dscam1 {ECO:0000312|FlyBase:FBgn0033159};
GN   Synonyms=Dscam {ECO:0000303|PubMed:10892653,
GN   ECO:0000312|FlyBase:FBgn0033159}, p270 {ECO:0000303|PubMed:10892653,
GN   ECO:0000312|FlyBase:FBgn0033159};
GN   ORFNames=CG17800 {ECO:0000312|FlyBase:FBgn0033159};
OS   Drosophila melanogaster (Fruit fly).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; Ephydroidea;
OC   Drosophilidae; Drosophila; Sophophora.
OX   NCBI_TaxID=7227 {ECO:0000312|Proteomes:UP000000803};
RN   [1] {ECO:0000312|EMBL:AAF71926.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 770-782; 826-832;
RP   926-943; 961-974; 1505-1518; 1672-1682 AND 1716-1725, FUNCTION, INTERACTION
RP   WITH DOCK, SUBCELLULAR LOCATION, ALTERNATIVE SPLICING, DEVELOPMENTAL STAGE,
RP   DOMAIN, PHOSPHORYLATION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10892653; DOI=10.1016/s0092-8674(00)80878-8;
RA   Schmucker D., Clemens J.C., Shu H., Worby C.A., Xiao J., Muda M.,
RA   Dixon J.E., Zipursky S.L.;
RT   "Drosophila Dscam is an axon guidance receptor exhibiting extraordinary
RT   molecular diversity.";
RL   Cell 101:671-684(2000).
RN   [2] {ECO:0000312|Proteomes:UP000000803}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=10731132; DOI=10.1126/science.287.5461.2185;
RA   Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D.,
RA   Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F.,
RA   George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N.,
RA   Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., Brandon R.C.,
RA   Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., Wan K.H., Doyle C.,
RA   Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., Abril J.F., Agbayani A.,
RA   An H.-J., Andrews-Pfannkoch C., Baldwin D., Ballew R.M., Basu A.,
RA   Baxendale J., Bayraktaroglu L., Beasley E.M., Beeson K.Y., Benos P.V.,
RA   Berman B.P., Bhandari D., Bolshakov S., Borkova D., Botchan M.R., Bouck J.,
RA   Brokstein P., Brottier P., Burtis K.C., Busam D.A., Butler H., Cadieu E.,
RA   Center A., Chandra I., Cherry J.M., Cawley S., Dahlke C., Davenport L.B.,
RA   Davies P., de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I.,
RA   Dietz S.M., Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C.,
RA   Dunn P., Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S.,
RA   Fleischmann W., Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M.,
RA   Glasser K., Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M.,
RA   Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., Hostin D.,
RA   Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., Jalali M., Kalush F.,
RA   Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., Kimmel B.E., Kodira C.D.,
RA   Kraft C.L., Kravitz S., Kulp D., Lai Z., Lasko P., Lei Y., Levitsky A.A.,
RA   Li J.H., Li Z., Liang Y., Lin X., Liu X., Mattei B., McIntosh T.C.,
RA   McLeod M.P., McPherson D., Merkulov G., Milshina N.V., Mobarry C.,
RA   Morris J., Moshrefi A., Mount S.M., Moy M., Murphy B., Murphy L.,
RA   Muzny D.M., Nelson D.L., Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R.,
RA   Pacleb J.M., Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V.,
RA   Reese M.G., Reinert K., Remington K., Saunders R.D.C., Scheeler F.,
RA   Shen H., Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J.,
RA   Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., Svirskas R.,
RA   Tector C., Turner R., Venter E., Wang A.H., Wang X., Wang Z.-Y.,
RA   Wassarman D.A., Weinstock G.M., Weissenbach J., Williams S.M., Woodage T.,
RA   Worley K.C., Wu D., Yang S., Yao Q.A., Ye J., Yeh R.-F., Zaveri J.S.,
RA   Zhan M., Zhang G., Zhao Q., Zheng L., Zheng X.H., Zhong F.N., Zhong W.,
RA   Zhou X., Zhu S.C., Zhu X., Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M.,
RA   Venter J.C.;
RT   "The genome sequence of Drosophila melanogaster.";
RL   Science 287:2185-2195(2000).
RN   [3] {ECO:0000312|Proteomes:UP000000803}
RP   GENOME REANNOTATION.
RC   STRAIN=Berkeley {ECO:0000312|Proteomes:UP000000803};
RX   PubMed=12537572; DOI=10.1186/gb-2002-3-12-research0083;
RA   Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S.,
RA   Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E.,
RA   Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P.,
RA   Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A.,
RA   Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., Stapleton M.,
RA   Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., Lewis S.E.;
RT   "Annotation of the Drosophila melanogaster euchromatic genome: a systematic
RT   review.";
RL   Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002).
RN   [4] {ECO:0000305}
RP   PHOSPHORYLATION.
RX   PubMed=12014990; DOI=10.1042/bj20020298;
RA   Muda M., Worby C.A., Simonson-Leff N., Clemens J.C., Dixon J.E.;
RT   "Use of double-stranded RNA-mediated interference to determine the
RT   substrates of protein tyrosine kinases and phosphatases.";
RL   Biochem. J. 366:73-77(2002).
RN   [5] {ECO:0000305}
RP   FUNCTION.
RX   PubMed=11856530; DOI=10.1016/s0896-6273(02)00570-6;
RA   Wang J., Zugates C.T., Liang I.H., Lee C.H., Lee T.;
RT   "Drosophila Dscam is required for divergent segregation of sister branches
RT   and suppresses ectopic bifurcation of axons.";
RL   Neuron 33:559-571(2002).
RN   [6] {ECO:0000305}
RP   FUNCTION, SUBUNIT, AND DOMAIN.
RX   PubMed=15339666; DOI=10.1016/j.cell.2004.08.021;
RA   Wojtowicz W.M., Flanagan J.J., Millard S.S., Zipursky S.L., Clemens J.C.;
RT   "Alternative splicing of Drosophila Dscam generates axon guidance receptors
RT   that exhibit isoform-specific homophilic binding.";
RL   Cell 118:619-633(2004).
RN   [7] {ECO:0000305}
RP   FUNCTION, ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=14758360; DOI=10.1038/ng1299;
RA   Neves G., Zucker J., Daly M., Chess A.;
RT   "Stochastic yet biased expression of multiple Dscam splice variants by
RT   individual cells.";
RL   Nat. Genet. 36:240-246(2004).
RN   [8] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, AND DOMAIN.
RX   PubMed=15339648; DOI=10.1016/j.neuron.2004.06.033;
RA   Wang J., Ma X., Yang J.S., Zheng X., Zugates C.T., Lee C.H., Lee T.;
RT   "Transmembrane/juxtamembrane domain-dependent Dscam distribution and
RT   function during mushroom body neuronal morphogenesis.";
RL   Neuron 43:663-672(2004).
RN   [9] {ECO:0000305}
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION,
RP   ALTERNATIVE SPLICING, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, PROTEOLYTIC
RP   CLEAVAGE, AND DISRUPTION PHENOTYPE.
RX   PubMed=16109846; DOI=10.1126/science.1116887;
RA   Watson F.L., Puettmann-Holgado R., Thomas F., Lamar D.L., Hughes M.,
RA   Kondo M., Rebel V.I., Schmucker D.;
RT   "Extensive diversity of Ig-superfamily proteins in the immune system of
RT   insects.";
RL   Science 309:1874-1878(2005).
RN   [10] {ECO:0000305}
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, DOMAIN, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=17482551; DOI=10.1016/j.cell.2007.04.013;
RA   Matthews B.J., Kim M.E., Flanagan J.J., Hattori D., Clemens J.C.,
RA   Zipursky S.L., Grueber W.B.;
RT   "Dendrite self-avoidance is controlled by Dscam.";
RL   Cell 129:593-604(2007).
RN   [11] {ECO:0000305}
RP   FUNCTION, SUBUNIT, AND DOMAIN.
RX   PubMed=17889655; DOI=10.1016/j.cell.2007.08.026;
RA   Wojtowicz W.M., Wu W., Andre I., Qian B., Baker D., Zipursky S.L.;
RT   "A vast repertoire of Dscam binding specificities arises from modular
RT   interactions of variable Ig domains.";
RL   Cell 130:1134-1145(2007).
RN   [12] {ECO:0007744|PDB:2V5M, ECO:0007744|PDB:2V5R, ECO:0007744|PDB:2V5S}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 36-423, SUBUNIT, DOMAIN,
RP   GLYCOSYLATION AT ASN-53 AND ASN-325, AND DISULFIDE BONDS.
RX   PubMed=17721508; DOI=10.1038/nature06147;
RA   Meijers R., Puettmann-Holgado R., Skiniotis G., Liu J.H., Walz T.,
RA   Wang J.H., Schmucker D.;
RT   "Structural basis of Dscam isoform specificity.";
RL   Nature 449:487-491(2007).
RN   [13] {ECO:0007744|PDB:3DMK}
RP   X-RAY CRYSTALLOGRAPHY (4.19 ANGSTROMS) OF 1-810, SUBUNIT, DOMAIN,
RP   GLYCOSYLATION AT ASN-53; ASN-325; ASN-492 AND ASN-577, DISULFIDE BONDS, AND
RP   MUTAGENESIS OF ARG-530.
RX   PubMed=18805093; DOI=10.1016/j.cell.2008.07.042;
RA   Sawaya M.R., Wojtowicz W.M., Andre I., Qian B., Wu W., Baker D.,
RA   Eisenberg D., Zipursky S.L.;
RT   "A double S shape provides the structural basis for the extraordinary
RT   binding specificity of Dscam isoforms.";
RL   Cell 134:1007-1018(2008).
RN   [14] {ECO:0007744|PDB:4WVR, ECO:0007744|PDB:4X5L, ECO:0007744|PDB:4X83, ECO:0007744|PDB:4X8X, ECO:0007744|PDB:4X9B, ECO:0007744|PDB:4X9F, ECO:0007744|PDB:4X9G, ECO:0007744|PDB:4X9H, ECO:0007744|PDB:4X9I, ECO:0007744|PDB:4XB7, ECO:0007744|PDB:4XB8}
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 34-431 AND 617-713, SUBUNIT,
RP   GLYCOSYLATION AT ASN-53 AND ASN-325, AND DISULFIDE BONDS.
RX   PubMed=27386517; DOI=10.1126/sciadv.1501118;
RA   Li S.A., Cheng L., Yu Y., Chen Q.;
RT   "Structural basis of Dscam1 homodimerization: Insights into context
RT   constraint for protein recognition.";
RL   Sci. Adv. 2:e1501118-e1501118(2016).
CC   -!- FUNCTION: Cell surface receptor involved in guidance and targeting of
CC       growing nerve axons (PubMed:10892653). Required during Bolwig's organ
CC       differentiation for accurate and efficient targeting of photoreceptor
CC       neuron axons to their synaptic targets in the brain via the P2
CC       intermediate target neuron (PubMed:10892653). Involved in isoneural
CC       self-avoidance during dendrite arborization but not in heteroneural
CC       recognition and repulsion during tiling by related neurons of the same
CC       class (PubMed:17482551). Involved in regulating axon bifurcation and
CC       divergent extension in the developing mushroom body (PubMed:11856530,
CC       PubMed:15339648). Essential for axon arborisation in ellipsoid body
CC       (PubMed:11856530, PubMed:15339648). Exhibits an extraordinary level of
CC       molecular diversity resulting from alternative splicing
CC       (PubMed:10892653). Isoforms differing in their ectodomain makeup show a
CC       high degree of functional redundancy while isoforms with different
CC       transmembrane domains are involved in different neuronal morphogenetic
CC       processes and are differentially targeted to dendrites or axons
CC       (PubMed:15339648). The vast majority of isoforms exhibit strong
CC       isoform-specific homophilic binding (PubMed:15339666, PubMed:17889655).
CC       Individual cells express a distinct randomly generated repertoire of
CC       isoforms (PubMed:14758360). Cell surfaces bearing identical repertoires
CC       of Dscam1 isoforms, such as those from the same cell, trigger
CC       recognition and avoidance (PubMed:17482551). A subset of isoforms is
CC       expressed in fat body cells and hemocytes, cells that are part of the
CC       insect immune response, and these isoforms are secreted into the
CC       hemolymph (PubMed:16109846). The secreted form comprising the
CC       ectodomain can bind to bacteria, such as Escherichia coli, and may act
CC       as an opsonin enhancing their phagocytosis by hemocytes
CC       (PubMed:16109846). {ECO:0000269|PubMed:10892653,
CC       ECO:0000269|PubMed:11856530, ECO:0000269|PubMed:14758360,
CC       ECO:0000269|PubMed:15339648, ECO:0000269|PubMed:15339666,
CC       ECO:0000269|PubMed:16109846, ECO:0000269|PubMed:17482551,
CC       ECO:0000269|PubMed:17889655}.
CC   -!- SUBUNIT: Homodimer (via extracellular region); alternative splicing
CC       produces a potential 19,008 different ectodomains and the majority of
CC       these show strong isoform-specific homodimerization (PubMed:15339666,
CC       PubMed:17721508, PubMed:17889655, PubMed:18805093, PubMed:27386517).
CC       Interacts (via cytoplasmic domain) with dock/dreadlocks (via SH2 and
CC       SH3 domains); the interaction is direct and may require Dscam1 to be
CC       phosphorylated (PubMed:10892653). {ECO:0000269|PubMed:10892653,
CC       ECO:0000269|PubMed:15339666, ECO:0000269|PubMed:17721508,
CC       ECO:0000269|PubMed:17889655, ECO:0000269|PubMed:18805093,
CC       ECO:0000269|PubMed:27386517}.
CC   -!- INTERACTION:
CC       Q0E9H9; Q0E9H9: Dscam1; NbExp=2; IntAct=EBI-2012532, EBI-2012532;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000305}; Single-pass membrane
CC       protein {ECO:0000255}. Cell projection, neuron projection
CC       {ECO:0000269|PubMed:10892653, ECO:0000269|PubMed:17482551}. Cell
CC       projection, axon {ECO:0000269|PubMed:10892653,
CC       ECO:0000269|PubMed:15339648, ECO:0000269|PubMed:17482551}. Perikaryon
CC       {ECO:0000269|PubMed:15339648, ECO:0000269|PubMed:17482551}. Cell
CC       projection, dendrite {ECO:0000269|PubMed:15339648}. Secreted
CC       {ECO:0000269|PubMed:16109846}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=14;
CC         Comment=Exhibits an extraordinary level of molecular diversity
CC         resulting from alternative splicing (PubMed:10892653). Transcripts
CC         are formed of 24 exons and mutually exclusive alternative splicing
CC         occurs for exons 4 (12 alternative exons, encoding the N-terminal
CC         half of Ig-like domain 2), 6 (48 alternative exons, encoding the N-
CC         terminal half of Ig-like domain 3), 9 (33 alternative exons, encoding
CC         the entire Ig-like domain 7) and 17 (2 alternative exons, encoding
CC         the transmembrane domain), potentially producing 38,016 different
CC         isoforms (PubMed:10892653). Selection of alternative exon clusters 4,
CC         6 and 9, encoding the ectodomain, occurs by a combination of
CC         stochastic selection with cell type and developmental stage dependent
CC         bias (PubMed:14758360). Almost all alternative exons are expressed in
CC         the brain while only a subset of exon 9 alternatives are used in
CC         isoforms expressed in fat body cells and hemocytes (PubMed:16109846).
CC         Isoform nomenclature takes the form W,X,Y,Z where W, X, Y and Z are
CC         the numerical identifiers of the exon 4, 6, 9 and 17 alternative
CC         present (Probable). {ECO:0000269|PubMed:10892653,
CC         ECO:0000269|PubMed:14758360, ECO:0000269|PubMed:16109846,
CC         ECO:0000305};
CC       Name=A {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=1,32,9,1
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-1; Sequence=Displayed;
CC       Name=G {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=1,5,5,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-2; Sequence=VSP_062106, VSP_062109, VSP_062119,
CC                                  VSP_062122, VSP_062133;
CC       Name=BF {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=1,10,3,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-3; Sequence=VSP_062105, VSP_062108, VSP_062115,
CC                                  VSP_062124, VSP_062133;
CC       Name=O {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=2,37,30,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-4; Sequence=VSP_062083, VSP_062087, VSP_062093,
CC                                  VSP_062095, VSP_062114, VSP_062126,
CC                                  VSP_062133;
CC       Name=Y {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=4,46,8,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-5; Sequence=VSP_062084, VSP_062085, VSP_062089,
CC                                  VSP_062101, VSP_062120, VSP_062125,
CC                                  VSP_062128, VSP_062129, VSP_062133;
CC       Name=AG {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=6,36,16,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-6; Sequence=VSP_062080, VSP_062085, VSP_062090,
CC                                  VSP_062099, VSP_062113, VSP_062133;
CC       Name=BE {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=7,9,30,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-7; Sequence=VSP_062082, VSP_062085, VSP_062092,
CC                                  VSP_062103, VSP_062114, VSP_062126,
CC                                  VSP_062133;
CC       Name=AM {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=7,20,9,1
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-8; Sequence=VSP_062082, VSP_062085, VSP_062092,
CC                                  VSP_062104, VSP_062112;
CC       Name=AO {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=7,42,8,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-9; Sequence=VSP_062082, VSP_062085, VSP_062092,
CC                                  VSP_062094, VSP_062120, VSP_062125,
CC                                  VSP_062128, VSP_062129, VSP_062133;
CC       Name=AP {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=8,4,26,1
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-10; Sequence=VSP_062079, VSP_062091, VSP_062102,
CC                                   VSP_062118;
CC       Name=AU {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=9,35,3,1
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-11; Sequence=VSP_062081, VSP_062086, VSP_062088,
CC                                   VSP_062098, VSP_062107, VSP_062115,
CC                                   VSP_062124;
CC       Name=AF {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=6,34,7,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-12; Sequence=VSP_062080, VSP_062085, VSP_062090,
CC                                   VSP_062097, VSP_062110, VSP_062116,
CC                                   VSP_062123, VSP_062127, VSP_062130,
CC                                   VSP_062131, VSP_062132, VSP_062133;
CC       Name=AE {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=6,30,17,1
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-13; Sequence=VSP_062080, VSP_062085, VSP_062090,
CC                                   VSP_062096, VSP_062111, VSP_062117;
CC       Name=BQ {ECO:0000312|FlyBase:FBgn0033159}; Synonyms=2,44,1,2
CC       {ECO:0000305};
CC         IsoId=Q0E9H9-14; Sequence=VSP_062083, VSP_062087, VSP_062093,
CC                                   VSP_062100, VSP_062121, VSP_062133;
CC   -!- TISSUE SPECIFICITY: Secreted into the hemolymph (at protein level)
CC       (PubMed:16109846). Expressed in brain and eye-antennal imaginal disks,
CC       including R3/R4 and R7 photoreceptor cells (PubMed:14758360).
CC       Individual R3/R4 cells express between 14 and 50 randomly generated
CC       mRNAs encoding distinct isoforms (PubMed:14758360).
CC       {ECO:0000269|PubMed:14758360, ECO:0000269|PubMed:16109846}.
CC   -!- DEVELOPMENTAL STAGE: Detected in 12-18 hr embryo extracts (at protein
CC       level) (PubMed:10892653). In the developing central nervous system of
CC       stage 16 embryos expression is confined to the axons of neuronal cells
CC       in the connectives and commissures of the ventral nerve cord (at
CC       protein level) (PubMed:10892653, PubMed:15339648). Expressed in
CC       Bolwig's organ of stage 16 embryos (at protein level)
CC       (PubMed:10892653). Expressed in da neurons of the peripheral nervous
CC       system in 2nd and 3rd instar larvae (at protein level)
CC       (PubMed:17482551). In wandering 3rd instar larvae, expressed in
CC       neuropil structures of the central nervous system (at protein level)
CC       (PubMed:15339648). Expressed in larval brain, fat body and hemocytes
CC       (at protein level) (PubMed:16109846). {ECO:0000269|PubMed:10892653,
CC       ECO:0000269|PubMed:15339648, ECO:0000269|PubMed:16109846,
CC       ECO:0000269|PubMed:17482551}.
CC   -!- DOMAIN: The ectodomain consists of 10 Ig-like domains. Ig-like domains
CC       2, 3 and 7 are highly variable in different isoforms due to alternative
CC       splicing (PubMed:10892653). Ig-like domains 1-8 are sufficient for
CC       homodimerization (PubMed:15339666). Dimerization only occurs when all 3
CC       variable Ig-like domains are identical (PubMed:15339666,
CC       PubMed:17889655). Intramolecular interactions between Ig-like domain
CC       pairs 1-4, 2-3 and 5-6 cause the ectodomain to adopt an S shape
CC       conformation, bringing the variable Ig-like domains 2, 3 and 7 into
CC       line to form an interaction surface (PubMed:18805093). During
CC       dimerization Ig-like domains 2, 3 and 7 self-interact in a modular
CC       fashion with their corresponding domain on the opposite molecule in an
CC       antiparallel orientation (PubMed:17721508, PubMed:17889655,
CC       PubMed:18805093). The Ig-like domain isoform encoded by exon 9.33 is
CC       unable to bind another copy of itself (PubMed:17889655).
CC       {ECO:0000269|PubMed:10892653, ECO:0000269|PubMed:15339666,
CC       ECO:0000269|PubMed:17721508, ECO:0000269|PubMed:17889655,
CC       ECO:0000269|PubMed:18805093}.
CC   -!- DOMAIN: The cytoplasmic domain is required to convert the recognition
CC       and adhesion of Dscam1 molecules on opposing membranes into a repulsion
CC       signal, possibly by recruiting components of signaling pathways
CC       involved in actin cytoskeleton regulation.
CC       {ECO:0000269|PubMed:17482551}.
CC   -!- DOMAIN: The 2 PXXP motifs and the polyproline tract are cooperatively
CC       involved in the binding of dock/dreadlocks through its SH3 domains
CC       (PubMed:10892653). PXXP motif 1 preferentially binds dock SH3 domain 1
CC       (PubMed:10892653). PXXP motif 2 preferentially binds dock SH3 domain 3
CC       (PubMed:10892653). The polyproline tract preferentially binds dock SH3
CC       domain 2 (PubMed:10892653). {ECO:0000269|PubMed:10892653}.
CC   -!- DOMAIN: The transmembrane domain is encoded by 2 mutually exclusive
CC       alternative exons, 17.1 and 17.2 (PubMed:10892653, PubMed:15339648).
CC       Isoforms bearing the transmembrane domain encoded by exon 17.1 are
CC       targeted to dendrites while those encoded by exon 17.2 are targeted to
CC       axons (PubMed:15339648). {ECO:0000269|PubMed:10892653,
CC       ECO:0000269|PubMed:15339648}.
CC   -!- PTM: Phosphorylated on tyrosine residues in the intracellular domain
CC       (PubMed:10892653, PubMed:12014990). Tyrosine protein kinase Src42A and
CC       possibly Src64B are involved in this phosphorylation (PubMed:12014990).
CC       {ECO:0000269|PubMed:10892653, ECO:0000269|PubMed:12014990}.
CC   -!- PTM: Glycosylation on Asn-53 and Asn-325 is involved in stabilizing
CC       dimerization. {ECO:0000269|PubMed:27386517}.
CC   -!- PTM: Proteolytically processed, probably to generate a secreted form.
CC       {ECO:0000269|PubMed:16109846}.
CC   -!- DISRUPTION PHENOTYPE: Early larval lethal with disruption of axon
CC       pathways in the central nervous system (PubMed:10892653). Dendrite
CC       arborisation is disrupted in da neurons of the peripheral nervous
CC       system, showing increased levels of overlap and fasciculation of
CC       dendrites from the same cell (PubMed:17482551). RNAi-mediated knockdown
CC       in embryonic and larval hemocytes reduces their ability to phagocytose
CC       bacteria (PubMed:16109846). {ECO:0000269|PubMed:10892653,
CC       ECO:0000269|PubMed:16109846, ECO:0000269|PubMed:17482551}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF260530; AAF71926.1; -; Genomic_DNA.
DR   EMBL; AE013599; AAF59271.2; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31042.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31045.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31049.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31053.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31057.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31067.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31069.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31073.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31075.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31076.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31078.1; -; Genomic_DNA.
DR   EMBL; AE013599; ABI31080.1; -; Genomic_DNA.
DR   EMBL; AE013599; AFH07931.1; -; Genomic_DNA.
DR   RefSeq; NP_001036491.1; NM_001043026.1. [Q0E9H9-5]
DR   RefSeq; NP_001036494.1; NM_001043029.1. [Q0E9H9-3]
DR   RefSeq; NP_001036498.1; NM_001043033.1. [Q0E9H9-4]
DR   RefSeq; NP_001036502.1; NM_001043037.1. [Q0E9H9-11]
DR   RefSeq; NP_001036506.1; NM_001043041.1. [Q0E9H9-7]
DR   RefSeq; NP_001036516.1; NM_001043051.1. [Q0E9H9-10]
DR   RefSeq; NP_001036518.1; NM_001043053.1. [Q0E9H9-6]
DR   RefSeq; NP_001036522.1; NM_001043057.1. [Q0E9H9-8]
DR   RefSeq; NP_001036524.1; NM_001043059.1. [Q0E9H9-9]
DR   RefSeq; NP_001036525.1; NM_001043060.1. [Q0E9H9-2]
DR   RefSeq; NP_001036527.1; NM_001043062.1. [Q0E9H9-12]
DR   RefSeq; NP_001036529.1; NM_001043064.1. [Q0E9H9-13]
DR   RefSeq; NP_001246176.1; NM_001259247.1. [Q0E9H9-14]
DR   RefSeq; NP_724543.1; NM_165514.1. [Q0E9H9-1]
DR   PDB; 2V5M; X-ray; 1.95 A; A=36-423.
DR   PDB; 2V5R; X-ray; 3.00 A; A/B=36-424.
DR   PDB; 2V5S; X-ray; 2.30 A; A/B=36-423.
DR   PDB; 3DMK; X-ray; 4.19 A; A/B/C=1-810.
DR   PDB; 4WVR; X-ray; 1.95 A; A/B/C/D=617-713.
DR   PDB; 4X5L; X-ray; 2.37 A; A/B/C/D=617-713.
DR   PDB; 4X83; X-ray; 1.90 A; A/B/C/D=34-425.
DR   PDB; 4X8X; X-ray; 2.50 A; A/B=34-425.
DR   PDB; 4X9B; X-ray; 2.20 A; A/B=34-428.
DR   PDB; 4X9F; X-ray; 2.35 A; A/B=34-425.
DR   PDB; 4X9G; X-ray; 3.40 A; A/B=34-425.
DR   PDB; 4X9H; X-ray; 2.95 A; A/B=34-431.
DR   PDB; 4X9I; X-ray; 2.90 A; A/B=34-427.
DR   PDB; 4XB7; X-ray; 4.00 A; A/B=34-431.
DR   PDB; 4XB8; X-ray; 3.20 A; A/B=34-427.
DR   PDB; 4XHQ; X-ray; 1.95 A; A=36-423.
DR   PDBsum; 2V5M; -.
DR   PDBsum; 2V5R; -.
DR   PDBsum; 2V5S; -.
DR   PDBsum; 3DMK; -.
DR   PDBsum; 4WVR; -.
DR   PDBsum; 4X5L; -.
DR   PDBsum; 4X83; -.
DR   PDBsum; 4X8X; -.
DR   PDBsum; 4X9B; -.
DR   PDBsum; 4X9F; -.
DR   PDBsum; 4X9G; -.
DR   PDBsum; 4X9H; -.
DR   PDBsum; 4X9I; -.
DR   PDBsum; 4XB7; -.
DR   PDBsum; 4XB8; -.
DR   PDBsum; 4XHQ; -.
DR   SMR; Q0E9H9; -.
DR   IntAct; Q0E9H9; 6.
DR   GlyCosmos; Q9NBA1; 3 sites, No reported glycans.
DR   GlyGen; Q0E9H9; 12 sites.
DR   iPTMnet; Q0E9H9; -.
DR   EnsemblMetazoa; FBtr0089016; FBpp0088088; FBgn0033159. [Q0E9H9-1]
DR   EnsemblMetazoa; FBtr0111053; FBpp0110345; FBgn0033159. [Q0E9H9-13]
DR   EnsemblMetazoa; FBtr0111054; FBpp0110346; FBgn0033159. [Q0E9H9-12]
DR   EnsemblMetazoa; FBtr0111055; FBpp0110347; FBgn0033159. [Q0E9H9-6]
DR   EnsemblMetazoa; FBtr0111061; FBpp0110353; FBgn0033159. [Q0E9H9-8]
DR   EnsemblMetazoa; FBtr0111062; FBpp0110355; FBgn0033159. [Q0E9H9-9]
DR   EnsemblMetazoa; FBtr0111063; FBpp0110356; FBgn0033159. [Q0E9H9-10]
DR   EnsemblMetazoa; FBtr0111067; FBpp0110361; FBgn0033159. [Q0E9H9-11]
DR   EnsemblMetazoa; FBtr0111077; FBpp0110371; FBgn0033159. [Q0E9H9-7]
DR   EnsemblMetazoa; FBtr0111078; FBpp0110372; FBgn0033159. [Q0E9H9-3]
DR   EnsemblMetazoa; FBtr0111082; FBpp0110376; FBgn0033159. [Q0E9H9-2]
DR   EnsemblMetazoa; FBtr0111089; FBpp0110384; FBgn0033159. [Q0E9H9-4]
DR   EnsemblMetazoa; FBtr0111099; FBpp0110394; FBgn0033159. [Q0E9H9-5]
DR   EnsemblMetazoa; FBtr0306781; FBpp0297697; FBgn0033159. [Q0E9H9-14]
DR   GeneID; 35652; -.
DR   KEGG; dme:Dmel_CG17800; -.
DR   UCSC; CG17800-RA; d. melanogaster. [Q0E9H9-1]
DR   AGR; FB:FBgn0033159; -.
DR   CTD; 35652; -.
DR   FlyBase; FBgn0033159; Dscam1.
DR   VEuPathDB; VectorBase:FBgn0033159; -.
DR   HOGENOM; CLU_001038_4_0_1; -.
DR   InParanoid; A0A0B4K6Z6; -.
DR   OrthoDB; 5982258at2759; -.
DR   Reactome; R-DME-376172; DSCAM interactions.
DR   BioGRID-ORCS; 35652; 0 hits in 3 CRISPR screens.
DR   EvolutionaryTrace; Q0E9H9; -.
DR   GenomeRNAi; 35652; -.
DR   PRO; PR:Q0E9H9; -.
DR   Proteomes; UP000000803; Chromosome 2R.
DR   Bgee; FBgn0033159; Expressed in cortex associated CNS glial cell (Drosophila) in post-embryonic organism and 228 other cell types or tissues.
DR   ExpressionAtlas; Q0E9H9; baseline and differential.
DR   GO; GO:0030424; C:axon; IDA:FlyBase.
DR   GO; GO:0030425; C:dendrite; IDA:FlyBase.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0043005; C:neuron projection; IDA:FlyBase.
DR   GO; GO:0043025; C:neuronal cell body; IDA:FlyBase.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISM:FlyBase.
DR   GO; GO:0003823; F:antigen binding; IDA:FlyBase.
DR   GO; GO:0008046; F:axon guidance receptor activity; IMP:FlyBase.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0048846; P:axon extension involved in axon guidance; IMP:FlyBase.
DR   GO; GO:0007411; P:axon guidance; IMP:FlyBase.
DR   GO; GO:0007413; P:axonal fasciculation; IMP:FlyBase.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0021551; P:central nervous system morphogenesis; IMP:FlyBase.
DR   GO; GO:0070593; P:dendrite self-avoidance; IDA:FlyBase.
DR   GO; GO:0050976; P:detection of mechanical stimulus involved in sensory perception of touch; IGI:FlyBase.
DR   GO; GO:0032490; P:detection of molecule of bacterial origin; IDA:FlyBase.
DR   GO; GO:0016319; P:mushroom body development; IMP:FlyBase.
DR   GO; GO:0048666; P:neuron development; IMP:FlyBase.
DR   GO; GO:0007422; P:peripheral nervous system development; IMP:FlyBase.
DR   GO; GO:0006909; P:phagocytosis; IMP:FlyBase.
DR   GO; GO:0050770; P:regulation of axonogenesis; IMP:FlyBase.
DR   GO; GO:0048814; P:regulation of dendrite morphogenesis; IMP:FlyBase.
DR   GO; GO:0007419; P:ventral cord development; IGI:FlyBase.
DR   CDD; cd00063; FN3; 6.
DR   CDD; cd20957; IgC2_3_Dscam; 1.
DR   CDD; cd20955; IgI_1_Dscam; 1.
DR   CDD; cd20953; IgI_2_Dscam; 1.
DR   CDD; cd20956; IgI_4_Dscam; 1.
DR   CDD; cd20958; IgI_5_Dscam; 1.
DR   CDD; cd20954; IgI_7_Dscam; 1.
DR   FunFam; 2.60.40.10:FF:000017; Down syndrome cell adhesion molecule b; 2.
DR   FunFam; 2.60.40.10:FF:000093; Down syndrome cell adhesion molecule, isoform B; 1.
DR   FunFam; 2.60.40.10:FF:000230; Down syndrome cell adhesion molecule, isoform D; 1.
DR   FunFam; 2.60.40.10:FF:000302; Down syndrome cell adhesion molecule, isoform D; 1.
DR   FunFam; 2.60.40.10:FF:000308; Down syndrome cell adhesion molecule, isoform D; 1.
DR   FunFam; 2.60.40.10:FF:000310; Down syndrome cell adhesion molecule, isoform D; 1.
DR   FunFam; 2.60.40.10:FF:000311; Down syndrome cell adhesion molecule, isoform D; 1.
DR   FunFam; 2.60.40.10:FF:000324; Down syndrome cell adhesion molecule, isoform D; 1.
DR   FunFam; 2.60.40.10:FF:000413; Down syndrome cell adhesion molecule, isoform F; 1.
DR   FunFam; 2.60.40.10:FF:000410; Down syndrome cell adhesion molecule, isoform H; 1.
DR   FunFam; 2.60.40.10:FF:000394; Down syndrome cell adhesion molecule, isoform J; 1.
DR   FunFam; 2.60.40.10:FF:000426; Down syndrome cell adhesion molecule, isoform J; 1.
DR   FunFam; 2.60.40.10:FF:000435; Down syndrome cell adhesion molecule, isoform J; 1.
DR   FunFam; 2.60.40.10:FF:000439; Down syndrome cell adhesion molecule, isoform J; 1.
DR   FunFam; 2.60.40.10:FF:000498; Down syndrome cell adhesion molecule, isoform J; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 16.
DR   InterPro; IPR056754; DSCAM/DSCAML_C.
DR   InterPro; IPR021012; Dscam1_C.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR10075; BASIGIN RELATED; 1.
DR   PANTHER; PTHR10075:SF14; CELL ADHESION MOLECULE DSCAM2-RELATED; 1.
DR   Pfam; PF12355; Dscam_C; 1.
DR   Pfam; PF00041; fn3; 5.
DR   Pfam; PF25059; FN3_DSCAM-DSCAML_C; 1.
DR   Pfam; PF07679; I-set; 4.
DR   Pfam; PF13927; Ig_3; 4.
DR   SMART; SM00060; FN3; 6.
DR   SMART; SM00409; IG; 10.
DR   SMART; SM00408; IGc2; 9.
DR   SUPFAM; SSF49265; Fibronectin type III; 3.
DR   SUPFAM; SSF48726; Immunoglobulin; 10.
DR   PROSITE; PS50853; FN3; 6.
DR   PROSITE; PS50835; IG_LIKE; 10.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Cell projection; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Membrane; Neurogenesis; Reference proteome; Repeat;
KW   Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000255"
FT   CHAIN           29..2016
FT                   /note="Cell adhesion molecule Dscam1"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5004171239"
FT   TOPO_DOM        29..1618
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1619..1639
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1640..2016
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          39..134
FT                   /note="Ig-like C2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          138..230
FT                   /note="Ig-like C2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          247..338
FT                   /note="Ig-like C2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          342..421
FT                   /note="Ig-like C2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          428..522
FT                   /note="Ig-like C2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          527..613
FT                   /note="Ig-like C2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          618..712
FT                   /note="Ig-like C2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          715..807
FT                   /note="Ig-like C2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          812..904
FT                   /note="Ig-like C2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          913..1007
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1012..1116
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1117..1213
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1217..1310
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1312..1394
FT                   /note="Ig-like C2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DOMAIN          1402..1495
FT                   /note="Fibronectin type-III 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          1499..1594
FT                   /note="Fibronectin type-III 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          1688..1719
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1787..1846
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1862..2016
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1685..1688
FT                   /note="PXXP motif 1; SH3-binding"
FT                   /evidence="ECO:0000269|PubMed:10892653"
FT   MOTIF           1727..1730
FT                   /note="PXXP motif 2; SH3-binding"
FT                   /evidence="ECO:0000269|PubMed:10892653"
FT   MOTIF           1842..1845
FT                   /note="YXXP motif 1; potential SH2-binding"
FT                   /evidence="ECO:0000303|PubMed:10892653"
FT   MOTIF           1875..1878
FT                   /note="YXXP motif 2; potential SH2-binding"
FT                   /evidence="ECO:0000303|PubMed:10892653"
FT   MOTIF           1925..1932
FT                   /note="Polyproline tract (probable SH3-binding)"
FT                   /evidence="ECO:0000269|PubMed:10892653"
FT   COMPBIAS        1826..1836
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1897..1918
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1944..1962
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1974..1993
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1994..2004
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        53
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:17721508, ECO:0000269|PubMed:18805093,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5M,
FT                   ECO:0007744|PDB:2V5R, ECO:0007744|PDB:3DMK,
FT                   ECO:0007744|PDB:4XHQ"
FT   CARBOHYD        325
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        492
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:18805093, ECO:0007744|PDB:3DMK"
FT   CARBOHYD        577
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498,
FT                   ECO:0000269|PubMed:18805093, ECO:0007744|PDB:3DMK"
FT   CARBOHYD        820
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1022
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1055
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        1186
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        61..117
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17721508, ECO:0000269|PubMed:18805093,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5M,
FT                   ECO:0007744|PDB:2V5R, ECO:0007744|PDB:2V5S,
FT                   ECO:0007744|PDB:3DMK, ECO:0007744|PDB:4X83,
FT                   ECO:0007744|PDB:4X8X, ECO:0007744|PDB:4X9B,
FT                   ECO:0007744|PDB:4X9F, ECO:0007744|PDB:4X9G,
FT                   ECO:0007744|PDB:4X9H, ECO:0007744|PDB:4X9I,
FT                   ECO:0007744|PDB:4XB7, ECO:0007744|PDB:4XB8,
FT                   ECO:0007744|PDB:4XHQ"
FT   DISULFID        160..217
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17721508, ECO:0000269|PubMed:18805093,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5M,
FT                   ECO:0007744|PDB:2V5R, ECO:0007744|PDB:3DMK,
FT                   ECO:0007744|PDB:4X8X"
FT   DISULFID        269..322
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        364..405
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17721508, ECO:0000269|PubMed:18805093,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5M,
FT                   ECO:0007744|PDB:2V5S, ECO:0007744|PDB:3DMK,
FT                   ECO:0007744|PDB:4X83, ECO:0007744|PDB:4X8X,
FT                   ECO:0007744|PDB:4X9B, ECO:0007744|PDB:4X9F,
FT                   ECO:0007744|PDB:4X9G, ECO:0007744|PDB:4X9H,
FT                   ECO:0007744|PDB:4X9I, ECO:0007744|PDB:4XB7,
FT                   ECO:0007744|PDB:4XB8, ECO:0007744|PDB:4XHQ"
FT   DISULFID        450..506
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:18805093, ECO:0007744|PDB:3DMK"
FT   DISULFID        547..596
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:18805093, ECO:0007744|PDB:3DMK"
FT   DISULFID        640..694
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:4X5L"
FT   DISULFID        736..790
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        833..890
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        1334..1382
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         138..161
FT                   /note="AQYYEADVNKEHVIRGNSAVIKCL -> SQFYITEAENEYVIKGNAAVVKCK
FT                   (in isoform AP)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062079"
FT   VAR_SEQ         138..149
FT                   /note="AQYYEADVNKEH -> NQFYGADILMEY (in isoform AG, isoform
FT                   AF and isoform AE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062080"
FT   VAR_SEQ         138..149
FT                   /note="AQYYEADVNKEH -> IQSYESEADNEY (in isoform AU)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062081"
FT   VAR_SEQ         138..149
FT                   /note="AQYYEADVNKEH -> NQFYEAEIMTEY (in isoform BE, isoform
FT                   AM and isoform AO)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062082"
FT   VAR_SEQ         138..149
FT                   /note="AQYYEADVNKEH -> SQHYEEDIHKAF (in isoform O and
FT                   isoform BQ)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062083"
FT   VAR_SEQ         138..149
FT                   /note="AQYYEADVNKEH -> QQFYESEVNNEY (in isoform Y)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062084"
FT   VAR_SEQ         155..161
FT                   /note="SAVIKCL -> AAVLKCS (in isoform Y, isoform AG,
FT                   isoform BE, isoform AM, isoform AO, isoform AF and isoform
FT                   AE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062085"
FT   VAR_SEQ         156..165
FT                   /note="AVIKCLIPSF -> VVMKCEIPSY (in isoform AU)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062086"
FT   VAR_SEQ         157..161
FT                   /note="VIKCL -> ILKCD (in isoform O and isoform BQ)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062087"
FT   VAR_SEQ         171..189
FT                   /note="EVVSWHTDEEENYFPGAEY -> FVDLWLDSEGRNYYPNNAAET (in
FT                   isoform AU)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062088"
FT   VAR_SEQ         171..189
FT                   /note="EVVSWHTDEEENYFPGAEY -> QVVSWQDEEGQLYGSLGDQQGT (in
FT                   isoform Y)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062089"
FT   VAR_SEQ         171..188
FT                   /note="EVVSWHTDEEENYFPGAE -> RVESWIDEEGTELRPSEN (in isoform
FT                   AG, isoform AF and isoform AE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062090"
FT   VAR_SEQ         171..188
FT                   /note="EVVSWHTDEEENYFPGAE -> QVEAWVDEEGMELWRNNATDA (in
FT                   isoform AP)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062091"
FT   VAR_SEQ         171..188
FT                   /note="EVVSWHTDEEENYFPGAE -> RVESWIDDEGNVLSFSDN (in isoform
FT                   BE, isoform AM and isoform AO)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062092"
FT   VAR_SEQ         171..187
FT                   /note="EVVSWHTDEEENYFPGA -> NVISWHSDEKENFYPGT (in isoform O
FT                   and isoform BQ)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062093"
FT   VAR_SEQ         242..279
FT                   /note="VSSSPPKINALTYKPNIVESMASTAILCPAQGYPAPSF -> IGARAPTFST
FT                   DSNSFSYTRSVGQSFALLCQAQAYPVPIM (in isoform AO)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062094"
FT   VAR_SEQ         242..278
FT                   /note="VSSSPPKINALTYKPNIVESMASTAILCPAQGYPAPS -> IGSKAPSVPTG
FT                   VMVFQQQVPLLSTFAMLCQAQAFPVPV (in isoform O)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062095"
FT   VAR_SEQ         242..267
FT                   /note="VSSSPPKINALTYKPNIVESMASTAI -> ISSAVPKVVSLAKFDMKTYSGS
FT                   STMAL (in isoform AE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062096"
FT   VAR_SEQ         242..267
FT                   /note="VSSSPPKINALTYKPNIVESMASTAI -> ISSSAPRTPALVQKPLELMVAH
FT                   TISL (in isoform AF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062097"
FT   VAR_SEQ         242..267
FT                   /note="VSSSPPKINALTYKPNIVESMASTAI -> ISAKAPVLAVDTKWSGIERHRD
FT                   MDIVL (in isoform AU)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062098"
FT   VAR_SEQ         243..279
FT                   /note="SSSPPKINALTYKPNIVESMASTAILCPAQGYPAPSF -> GAKAPTFSLEY
FT                   KLIEVQKSKGTAFALLCQAQAFPVPII (in isoform AG)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062099"
FT   VAR_SEQ         243..279
FT                   /note="SSSPPKINALTYKPNIVESMASTAILCPAQGYPAPSF -> GSKAPTFATAS
FT                   KISSLLGSSSSDIVLLCQAQAFPVPYT (in isoform BQ)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062100"
FT   VAR_SEQ         243..279
FT                   /note="SSSPPKINALTYKPNIVESMASTAILCPAQGYPAPSF -> GAKAPTFSGES
FT                   KSFTFVKEISTSFALLCQAQAFPVPII (in isoform Y)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062101"
FT   VAR_SEQ         243..278
FT                   /note="SSSPPKINALTYKPNIVESMASTAILCPAQGYPAPS -> GSVSPQLSGNGN
FT                   QEHITLTRVPKMGSVTLMCPAQAYPVPF (in isoform AP)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062102"
FT   VAR_SEQ         243..276
FT                   /note="SSSPPKINALTYKPNIVESMASTAILCPAQGYPA -> GSVRPKVNPQDKHQ
FT                   FIDVELASSYSLLCMAQSYPT (in isoform BE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062103"
FT   VAR_SEQ         243..270
FT                   /note="SSSPPKINALTYKPNIVESMASTAILCP -> GSVAPKVDMQDKFGVNIRQA
FT                   NNSLNLLCK (in isoform AM)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062104"
FT   VAR_SEQ         243..267
FT                   /note="SSSPPKINALTYKPNIVESMASTAI -> GSVKPKINVQDKLQTREISQGIG
FT                   IAL (in isoform BF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062105"
FT   VAR_SEQ         243..267
FT                   /note="SSSPPKINALTYKPNIVESMASTAI -> GSVGPKLTSGDDSRTVRIRQEDS
FT                   VTL (in isoform G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062106"
FT   VAR_SEQ         273..279
FT                   /note="GYPAPSF -> AYPVPIS (in isoform AU)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062107"
FT   VAR_SEQ         273..279
FT                   /note="GYPAPSF -> SYPIPAH (in isoform BF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062108"
FT   VAR_SEQ         273..279
FT                   /note="GYPAPSF -> AYPVPVY (in isoform G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062109"
FT   VAR_SEQ         274
FT                   /note="Y -> F (in isoform AF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062110"
FT   VAR_SEQ         276..278
FT                   /note="APS -> VPV (in isoform AE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062111"
FT   VAR_SEQ         276..278
FT                   /note="APS -> MPA (in isoform AM)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062112"
FT   VAR_SEQ         617..710
FT                   /note="PPQVLPFSFGESAADVGDIASANCVVPKGDLPLEIRWSLNSAPIVNGENGFT
FT                   LVRLNKRTSLLNIDSLNAFHRGVYKCIATNPAGTSEYVAELQ -> APKIAPFDFGDEP
FT                   SNFGESASVQCLVTSGDFPVSFAWLFNGREINENVYDVSMVKLGKKISALSIDIVRDHH
FT                   AGNYTCVAVNRATSVNFTAELV (in isoform AG)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062113"
FT   VAR_SEQ         617..644
FT                   /note="PPQVLPFSFGESAADVGDIASANCVVPK -> LPRIIPFAFEEGPAQVGQYL
FT                   TLHCSVPG (in isoform O and isoform BE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062114"
FT   VAR_SEQ         617..643
FT                   /note="PPQVLPFSFGESAADVGDIASANCVVP -> LPQVVPFDFGEESINELDMVS
FT                   ASCTVN (in isoform BF and isoform AU)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062115"
FT   VAR_SEQ         617..621
FT                   /note="PPQVL -> APQIS (in isoform AF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062116"
FT   VAR_SEQ         619..710
FT                   /note="QVLPFSFGESAADVGDIASANCVVPKGDLPLEIRWSLNSAPIVNGENGFTLV
FT                   RLNKRTSLLNIDSLNAFHRGVYKCIATNPAGTSEYVAELQ -> KIAHFDFGDHAVNFE
FT                   ESVSVNCLIYLGDLPMDITWLFNGAHINAYTGVSIVKGGKKASILTIDSVHAGHAGNYT
FT                   CKARNDADSAEYSAELI (in isoform AE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062117"
FT   VAR_SEQ         619..710
FT                   /note="QVLPFSFGESAADVGDIASANCVVPKGDLPLEIRWSLNSAPIVNGENGFTLV
FT                   RLNKRTSLLNIDSLNAFHRGVYKCIATNPAGTSEYVAELQ -> KITPFDFGAEPTNVE
FT                   DSVSVTCLISSGDLPIDIEWFFNDYGISSYSGINVVKGGKRNSMLSIDNVQARHAGKYS
FT                   CRAKNYAAAVNYSTELI (in isoform AP)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062118"
FT   VAR_SEQ         619..621
FT                   /note="QVL -> SIA (in isoform G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062119"
FT   VAR_SEQ         620..641
FT                   /note="VLPFSFGESAADVGDIASANCV -> IQAFDFGSEAANTGEMAGGFCM (in
FT                   isoform Y and isoform AO)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062120"
FT   VAR_SEQ         621..710
FT                   /note="LPFSFGESAADVGDIASANCVVPKGDLPLEIRWSLNSAPIVNGENGFTLVRL
FT                   NKRTSLLNIDSLNAFHRGVYKCIATNPAGTSEYVAELQ -> VPFDFGEETINMNDMVS
FT                   ATCTVNKGDTPLELYWTTAPDPTTGVGRLMSNDGILITKTTQRISMLSIESVHARHRAN
FT                   YTCVARNAAGVIYHTAELR (in isoform BQ)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062121"
FT   VAR_SEQ         627..710
FT                   /note="ESAADVGDIASANCVVPKGDLPLEIRWSLNSAPIVNGENGFTLVRLNKRTSL
FT                   LNIDSLNAFHRGVYKCIATNPAGTSEYVAELQ -> DDPVNTGENAGVQCMVQKGDVPI
FT                   TIKWTLNSRPIINGEEGITILKLSPKTSVLNIAAVEQDHRGVFKCIAENKAGSSFTTSE
FT                   LK (in isoform G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062122"
FT   VAR_SEQ         627..638
FT                   /note="ESAADVGDIASA -> DEPLNRGEVASV (in isoform AF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062123"
FT   VAR_SEQ         649..710
FT                   /note="LEIRWSLNSAPIVNGENGFTLVRLNKRTSLLNIDSLNAFHRGVYKCIATNPA
FT                   GTSEYVAELQ -> VDIYWTKNGGRVYTNDGLIVTRNSQRLSVLSIESVRARHAGNYSC
FT                   VATNNAGAITQSAMLA (in isoform BF and isoform AU)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062124"
FT   VAR_SEQ         649
FT                   /note="L -> M (in isoform Y and isoform AO)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062125"
FT   VAR_SEQ         650..712
FT                   /note="EIRWSLNSAPIVNGENGFTLVRLNKRTSLLNIDSLNAFHRGVYKCIATNPAG
FT                   TSEYVAELQVN -> NIDWTLDGQAISEDLGITTSRVGRRGSVLTIEAVEASHAGNFTC
FT                   HARNLAGHQQFTTPLNVY (in isoform O and isoform BE)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062126"
FT   VAR_SEQ         650..659
FT                   /note="EIRWSLNSAP -> DIYWTLNSAL (in isoform AF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062127"
FT   VAR_SEQ         654
FT                   /note="S -> T (in isoform Y and isoform AO)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062128"
FT   VAR_SEQ         661..710
FT                   /note="VNGENGFTLVRLNKRTSLLNIDSLNAFHRGVYKCIATNPAGTSEYVAELQ
FT                   -> ITGEHGFSLSRLNPRTSSLSIDSLEARHRGLYRCIASNKAGSAEYSAELH (in
FT                   isoform Y and isoform AO)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062129"
FT   VAR_SEQ         665
FT                   /note="N -> M (in isoform AF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062130"
FT   VAR_SEQ         678..691
FT                   /note="LLNIDSLNAFHRGV -> SLNVDSLEAVHRGS (in isoform AF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062131"
FT   VAR_SEQ         697..710
FT                   /note="TNPAGTSEYVAELQ -> NNSAGYAEYVSTLD (in isoform AF)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062132"
FT   VAR_SEQ         1598..1649
FT                   /note="SRDLPELSAEDTIRIILSNLNLVVPVVAALLVIIIAIIVICILRSKGNHHKD
FT                   -> LDDGSGHGNVHTRIRLPAWMPEWLDLNFMVPLIATVVVVAVGICVVCVALSRRRAD
FT                   DMRGGQKDVYY (in isoform G, isoform BF, isoform O, isoform
FT                   Y, isoform AG, isoform BE, isoform AO, isoform AF and
FT                   isoform BQ)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_062133"
FT   MUTAGEN         530
FT                   /note="R->W: In DscamR496W; loss of function probably due
FT                   to disruption of the intramolecular binding interface
FT                   between Ig-like domains 5 and 6; dorsal lobe nerve tract
FT                   does not form and the medial lobe fails to extend to the
FT                   midline."
FT                   /evidence="ECO:0000269|PubMed:18805093"
FT   CONFLICT        251
FT                   /note="A -> T (in Ref. 1; AAF71926)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="P -> S (in Ref. 1; AAF71926)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        411
FT                   /note="Q -> R (in Ref. 1; AAF71926)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1804
FT                   /note="H -> L (in Ref. 1; AAF71926)"
FT                   /evidence="ECO:0000305"
FT   STRAND          37..43
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          47..52
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   TURN            53..55
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          57..59
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          62..67
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          70..75
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   TURN            85..87
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          88..91
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   TURN            92..94
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          95..98
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   HELIX           103..105
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   HELIX           108..111
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          112..120
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          125..127
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          131..136
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          148..151
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          156..158
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   HELIX           164..166
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   TURN            167..169
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          170..175
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   TURN            178..180
FT                   /evidence="ECO:0007829|PDB:4X8X"
FT   STRAND          182..184
FT                   /evidence="ECO:0007829|PDB:4X9B"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:4XHQ"
FT   STRAND          191..195
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          201..203
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   HELIX           208..211
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          214..221
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   TURN            222..224
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          227..229
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          234..239
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          245..252
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          255..261
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          266..268
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          271..275
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          278..284
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          291..293
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          297..303
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          306..309
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   HELIX           314..316
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          318..326
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          329..348
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          350..355
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          360..369
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          373..378
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          381..384
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          387..394
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   HELIX           397..399
FT                   /evidence="ECO:0007829|PDB:4XHQ"
FT   STRAND          401..408
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          413..423
FT                   /evidence="ECO:0007829|PDB:4X83"
FT   STRAND          636..642
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   STRAND          650..655
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   STRAND          658..660
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   HELIX           664..666
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   STRAND          667..673
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   STRAND          676..683
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   HELIX           686..688
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   STRAND          690..697
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   STRAND          702..709
FT                   /evidence="ECO:0007829|PDB:4WVR"
FT   DISULFID        Q0E9H9-2:61..117
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17721508, ECO:0000269|PubMed:18805093,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5M,
FT                   ECO:0007744|PDB:2V5R, ECO:0007744|PDB:2V5S,
FT                   ECO:0007744|PDB:3DMK, ECO:0007744|PDB:4X83,
FT                   ECO:0007744|PDB:4X8X, ECO:0007744|PDB:4X9B,
FT                   ECO:0007744|PDB:4X9F, ECO:0007744|PDB:4X9G,
FT                   ECO:0007744|PDB:4X9H, ECO:0007744|PDB:4X9I,
FT                   ECO:0007744|PDB:4XB7, ECO:0007744|PDB:4XB8,
FT                   ECO:0007744|PDB:4XHQ"
FT   DISULFID        Q0E9H9-2:641..695
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4WVR"
FT   DISULFID        Q0E9H9-3:61..117
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17721508, ECO:0000269|PubMed:18805093,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5M,
FT                   ECO:0007744|PDB:2V5R, ECO:0007744|PDB:2V5S,
FT                   ECO:0007744|PDB:3DMK, ECO:0007744|PDB:4X83,
FT                   ECO:0007744|PDB:4X8X, ECO:0007744|PDB:4X9B,
FT                   ECO:0007744|PDB:4X9F, ECO:0007744|PDB:4X9G,
FT                   ECO:0007744|PDB:4X9H, ECO:0007744|PDB:4X9I,
FT                   ECO:0007744|PDB:4XB7, ECO:0007744|PDB:4XB8,
FT                   ECO:0007744|PDB:4XHQ"
FT   DISULFID        Q0E9H9-4:641..694
FT                   /evidence="ECO:0000269|PubMed:18805093,
FT                   ECO:0007744|PDB:3DMK"
FT   DISULFID        Q0E9H9-5:160..220
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X9B, ECO:0007744|PDB:4XB7"
FT   DISULFID        Q0E9H9-6:160..217
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X9F, ECO:0007744|PDB:4X9G"
FT   DISULFID        Q0E9H9-7:160..217
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X83"
FT   DISULFID        Q0E9H9-7:270..323
FT                   /evidence="ECO:0000269|PubMed:17721508,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5R,
FT                   ECO:0007744|PDB:4X8X, ECO:0007744|PDB:4X9F"
FT   DISULFID        Q0E9H9-7:641..694
FT                   /evidence="ECO:0000269|PubMed:18805093,
FT                   ECO:0007744|PDB:3DMK"
FT   DISULFID        Q0E9H9-8:160..217
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X83"
FT   DISULFID        Q0E9H9-8:641..695
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:4X5L"
FT   DISULFID        Q0E9H9-9:160..217
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X83"
FT   DISULFID        Q0E9H9-10:160..220
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X9H"
FT   DISULFID        Q0E9H9-10:276..329
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X9H, ECO:0007744|PDB:4XB7"
FT   BINDING         Q0E9H9-11:144
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4XB8"
FT   BINDING         Q0E9H9-11:146
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4XB8"
FT   BINDING         Q0E9H9-11:161
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /note="ligand shared between homodimeric partners"
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4XB8"
FT   DISULFID        Q0E9H9-11:160..219
FT                   /evidence="ECO:0000269|PubMed:17721508,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5R,
FT                   ECO:0007744|PDB:4X9I, ECO:0007744|PDB:4XB8"
FT   CARBOHYD        Q0E9H9-12:325
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:17721508,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5M,
FT                   ECO:0007744|PDB:4XHQ"
FT   DISULFID        Q0E9H9-12:160..217
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X9F, ECO:0007744|PDB:4X9G"
FT   DISULFID        Q0E9H9-12:269..322
FT                   /evidence="ECO:0000269|PubMed:17721508,
FT                   ECO:0000269|PubMed:27386517, ECO:0007744|PDB:2V5M,
FT                   ECO:0007744|PDB:2V5S, ECO:0007744|PDB:4XHQ"
FT   CARBOHYD        Q0E9H9-13:325
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:18805093,
FT                   ECO:0007744|PDB:3DMK"
FT   DISULFID        Q0E9H9-13:160..217
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X9F, ECO:0007744|PDB:4X9G"
FT   DISULFID        Q0E9H9-13:270..323
FT                   /evidence="ECO:0000269|PubMed:18805093,
FT                   ECO:0007744|PDB:3DMK"
FT   DISULFID        Q0E9H9-14:270..323
FT                   /evidence="ECO:0000269|PubMed:27386517,
FT                   ECO:0007744|PDB:4X83, ECO:0007744|PDB:4X9B,
FT                   ECO:0007744|PDB:4X9G, ECO:0007744|PDB:4X9I,
FT                   ECO:0007744|PDB:4XB8"
SQ   SEQUENCE   2016 AA;  222102 MW;  DF36AD62BA36FE41 CRC64;
     MNMPNERLKW LMLFAAVALI ACGSQTLAAN PPDADQKGPV FLKEPTNRID FSNSTGAEIE
     CKASGNPMPE IIWIRSDGTA VGDVPGLRQI SSDGKLVFPP FRAEDYRQEV HAQVYACLAR
     NQFGSIISRD VHVRAVVAQY YEADVNKEHV IRGNSAVIKC LIPSFVADFV EVVSWHTDEE
     ENYFPGAEYD GKYLVLPSGE LHIREVGPED GYKSYQCRTK HRLTGETRLS ATKGRLVITE
     PVSSSPPKIN ALTYKPNIVE SMASTAILCP AQGYPAPSFR WYKFIEGTTR KQAVVLNDRV
     KQVSGTLIIK DAVVEDSGKY LCVVNNSVGG ESVETVLTVT APLSAKIDPP TQTVDFGRPA
     VFTCQYTGNP IKTVSWMKDG KAIGHSEPVL RIESVKKEDK GMYQCFVRND QESAEASAEL
     KLGGRFDPPV IRQAFQEETM EPGPSVFLKC VAGGNPTPEI SWELDGKKIA NNDRYQVGQY
     VTVNGDVVSY LNITSVHAND GGLYKCIAKS KVGVAEHSAK LNVYGLPYIR QMEKKAIVAG
     ETLIVTCPVA GYPIDSIVWE RDNRALPINR KQKVFPNGTL IIENVERNSD QATYTCVAKN
     QEGYSARGSL EVQVMVPPQV LPFSFGESAA DVGDIASANC VVPKGDLPLE IRWSLNSAPI
     VNGENGFTLV RLNKRTSLLN IDSLNAFHRG VYKCIATNPA GTSEYVAELQ VNVPPRWILE
     PTDKAFAQGS DAKVECKADG FPKPQVTWKK AVGDTPGEYK DLKKSDNIRV EEGTLHVDNI
     QKTNEGYYLC EAINGIGSGL SAVIMISVQA PPEFTEKLRN QTARRGEPAV LQCEAKGEKP
     IGILWNMNNM RLDPKNDNRY TIREEILSTG VMSSLSIKRT ERSDSALFTC VATNAFGSDD
     ASINMIVQEV PEMPYALKVL DKSGRSVQLS WAQPYDGNSP LDRYIIEFKR SRASWSEIDR
     VIVPGHTTEA QVQKLSPATT YNIRIVAENA IGTSQSSEAV TIITAEEAPS GKPQNIKVEP
     VNQTTMRVTW KPPPRTEWNG EILGYYVGYK LSNTNSSYVF ETINFITEEG KEHNLELQNL
     RVYTQYSVVI QAFNKIGAGP LSEEEKQFTA EGTPSQPPSD TACTTLTSQT IRVGWVSPPL
     ESANGVIKTY KVVYAPSDEW YDETKRHYKK TASSDTVLHG LKKYTNYTMQ VLATTAGGDG
     VRSVPIHCQT EPDVPEAPTD VKALVMGNAA ILVSWRPPAQ PNGIITQYTV YSKAEGAETE
     TKTQKVPHYQ MSFEATELEK NKPYEFWVTA STTIGEGQQS KSIVAMPSDQ VPAKIASFDD
     TFTATFKEDA KMPCLAVGAP QPEITWKIKG VEFSANDRMR VLPDGSLLIK SVNRQDAGDY
     SCHAENSIAK DSITHKLIVL APPQSPHVTL SATTTDALTV KLKPHEGDTA PLHGYTLHYK
     PEFGEWETSE VSVDSQKHNI EGLLCGSRYQ VYATGFNNIG AGEASDILNT RTKGQKPKLP
     EKPRFIEVSS NSVSLHFKAW KDGGCPMSHF VVESKKRDQI EWNQISNNVK PDNNYVVLDL
     EPATWYNLRI TAHNSAGFTV AEYDFATLTV TGGTIAPSRD LPELSAEDTI RIILSNLNLV
     VPVVAALLVI IIAIIVICIL RSKGNHHKDD VVYNQTMGPG ATLDKRRPDL RDELGYIAPP
     NRKLPPVPGS NYNTCDRIKR GRGGLRSNHS TWDPRRNPNL YEELKAPPVP MHGNHYGHAH
     GNAECHYRHP GMEDEICPYA TFHLLGFREE MDPTKAMNFQ TFPHQNGHAG PVPGHAGTML
     PPGHPGHVHS RSGSQSMPRA NRYQRKNSQG GQSSIYTPAP EYDDPANCAE EDQYRRYTRV
     NSQGGSLYSG PGPEYDDPAN CAPEEDQYGS QYGGPYGQPY DHYGSRGSMG RRSIGSARNP
     GNGSPEPPPP PPRNHDMSNS SFNDSKESNE ISEAECDRDH GPRGNYGAVK RSPQPKDQRT
     TEEMRKLIER NETGPKQLQL QQANGAGFTA YDTMAV
//
